Cargando…
Gastrointestinal adverse events of immunotherapy
Cancer immunotherapy with immune-checkpoint inhibitors (ICIs) has emerged as an effective treatment for different types of cancer. ICIs are monoclonal antibodies that inhibit the signaling pathway that suppress antitumor T-cell activity. Patients benefit from increased overall and progression-free s...
Autores principales: | Cappello, Giovanni, Molea, Francesca, Campanella, Delia, Galioto, Francesca, Russo, Filippo, Regge, Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185848/ https://www.ncbi.nlm.nih.gov/pubmed/35707753 http://dx.doi.org/10.1259/bjro.20210027 |
Ejemplares similares
-
Imaging of Adverse Events Related to Checkpoint Inhibitor Therapy
por: Vani, Vanina, et al.
Publicado: (2020) -
A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST)
por: Cappello, Giovanni, et al.
Publicado: (2023) -
Effect of dose splitting of a low-volume bowel preparation macrogol-based solution on CT colonography tagging quality
por: Mistretta, Francesco, et al.
Publicado: (2022) -
Gastrointestinal disorders as immune-related adverse events
por: Balducci, Daniele, et al.
Publicado: (2021) -
Adverse Events of Oncologic Immunotherapy and Their Management
por: Barber, Fedricker Diane
Publicado: (2019)